Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan 29;14(4):1287-1288.
doi: 10.1093/ckj/sfab024. eCollection 2021 Apr.

Successful treatment of a COVID-19 patient with thrombotic microangiopathy

Seda Safak  1 , Elif Aksoy  1 , Ahmet Burak Dirim  1 , Erol Demir  1 , Nurana Garayeva  1 , Ozgur Akin Oto  1 , Ayse Serra Artan  1 , Halil Yazici  1 , Sevgi Besisik  2 , Aydin Turkmen  1
Affiliations

Successful treatment of a COVID-19 patient with thrombotic microangiopathy

Seda Safak et al. Clin Kidney J. .
No abstract available

PubMed Disclaimer

Figures

FIGURE 1.
FIGURE 1.
The course of the laboratory results during COVID-19 treatment.
See this image and copyright information in PMC

References

    1. Merrill JT, Erkan D, Winakur J. et al. Emerging evidence of a COVID-19 thrombotic syndrome has treatment implications. Nat Rev Rheumatol 2020; 16: 581–589 - PMC - PubMed
    1. Su H, Yang M, Wan C. et al. Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Kidney Int 2020; 98: 219–227 - PMC - PubMed
    1. Jhaveri KD, Meir LR, Flores Chang BS. et al. Thrombotic microangiopathy in a patient with COVID-19. Kidney Int 2020; 98: 509–512 - PMC - PubMed
    1. Ville S, Bot SLE, Chapelet-Debout A. et al. Atypical HUS relapse triggered by COVID-19 Kidney Int 2021; 99: 267–268 - PMC - PubMed
    1. Iba T, Levy JH, Levi M. et al. The unique characteristics of COVID-19 coagulopathy. Crit Care 2020; 24: 360. - PMC - PubMed